Efficacy of Treatment With an Oral IL-23 Receptor Antagonist Peptide in Patients With Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis
N. Engl. J. Med 2024 Feb 08;390(6)510-521, R Bissonnette, A Pinter, LK Ferris, S Gerdes, P Rich, R Vender, M Miller, YK Shen, A Kannan, S Li, C DeKlotz, K PappFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.